43 related articles for article (PubMed ID: 12796021)
1. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
[TBL] [Abstract][Full Text] [Related]
2. HER2 Signaling in Breast Cancer.
Shin I
Adv Exp Med Biol; 2021; 1187():53-79. PubMed ID: 33983573
[TBL] [Abstract][Full Text] [Related]
3. CTCs Expression Profiling for Advanced Breast Cancer Monitoring.
Pereira-Veiga T; Martínez-Fernández M; Abuin C; Piñeiro R; Cebey V; Cueva J; Palacios P; Blanco C; Muinelo-Romay L; Abalo A; Costa C; López-López R
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817194
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
Messaritakis I; Politaki E; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Kallergi G; Souglakos J; Georgoulias V
PLoS One; 2017; 12(7):e0181211. PubMed ID: 28719656
[TBL] [Abstract][Full Text] [Related]
5. TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC).
Messaritakis I; Stoltidis D; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Politaki E; Apostolaki S; Souglakos J; Georgoulias V
Sci Rep; 2017 Mar; 7():45351. PubMed ID: 28349943
[TBL] [Abstract][Full Text] [Related]
6. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
[TBL] [Abstract][Full Text] [Related]
7. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients.
Koren A; Sodja E; Rijavec M; Jez M; Kovac V; Korosec P; Cufer T
Cell Oncol (Dordr); 2015 Oct; 38(5):387-95. PubMed ID: 26306784
[TBL] [Abstract][Full Text] [Related]
9. CTC enumeration and characterization: moving toward personalized medicine.
Toss A; Mu Z; Fernandez S; Cristofanilli M
Ann Transl Med; 2014 Nov; 2(11):108. PubMed ID: 25489582
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis.
Liao Y; Wang SY; Meng XY; Yang J; Shi MJ; Liu HL; Chen FF; Xiong B
Med Oncol; 2014 Dec; 31(12):343. PubMed ID: 25412938
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes.
Ju JH; Oh S; Lee KM; Yang W; Nam KS; Moon HG; Noh DY; Kim CG; Park G; Park JB; Lee T; Arteaga CL; Shin I
Cell Death Differ; 2015 Apr; 22(4):665-76. PubMed ID: 25342465
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.
Tenori L; Oakman C; Morris PG; Gralka E; Turner N; Cappadona S; Fornier M; Hudis C; Norton L; Luchinat C; Di Leo A
Mol Oncol; 2015 Jan; 9(1):128-39. PubMed ID: 25151299
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer.
Markiewicz A; Książkiewicz M; Seroczyńska B; Skokowski J; Szade J; Wełnicka-Jaśkiewicz M; Zaczek AJ
Cancers (Basel); 2013 Nov; 5(4):1485-503. PubMed ID: 24217115
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.
Androulakis N; Agelaki S; Perraki M; Apostolaki S; Bozionelou V; Pallis A; Kalbakis K; Xyrafas A; Mavroudis D; Georgoulias V
Br J Cancer; 2012 Jun; 106(12):1917-25. PubMed ID: 22669159
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.
Strati A; Markou A; Parisi C; Politaki E; Mavroudis D; Georgoulias V; Lianidou E
BMC Cancer; 2011 Oct; 11():422. PubMed ID: 21967632
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.
Saloustros E; Perraki M; Apostolaki S; Kallergi G; Xyrafas A; Kalbakis K; Agelaki S; Kalykaki A; Georgoulias V; Mavroudis D
Breast Cancer Res; 2011 Jun; 13(3):R60. PubMed ID: 21663668
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome.
Serrano MJ; Lorente JA; Delgado Rodríguez M; Fernández A; Fernández M; de la Torre C; Fernández Izquierdo J; Sánchez Rovira P
Clin Transl Oncol; 2011 Mar; 13(3):204-8. PubMed ID: 21421466
[TBL] [Abstract][Full Text] [Related]
18. Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
Daskalaki A; Agelaki S; Perraki M; Apostolaki S; Xenidis N; Stathopoulos E; Kontopodis E; Hatzidaki D; Mavroudis D; Georgoulias V
Br J Cancer; 2009 Aug; 101(4):589-97. PubMed ID: 19623181
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.
Wang L; Wang Y; Liu Y; Cheng M; Wu X; Wei H
J Exp Clin Cancer Res; 2009 Apr; 28(1):57. PubMed ID: 19397830
[TBL] [Abstract][Full Text] [Related]
20. An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.
Pachmann K; Dengler R; Lobodasch K; Fröhlich F; Kroll T; Rengsberger M; Schubert R; Pachmann U
J Cancer Res Clin Oncol; 2008 Jan; 134(1):59-65. PubMed ID: 17611779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
